Recursion Pharmaceuticals, Inc. (RXRX)
4.15
-0.21
(-4.82%)
USD |
NASDAQ |
Oct 12, 10:01
Recursion Pharmaceuticals Net Income (TTM) : -518.88M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -518.88M |
| March 31, 2026 | -559.78M |
| December 31, 2025 | -644.76M |
| September 30, 2025 | -715.54M |
| June 30, 2025 | -649.13M |
| March 31, 2025 | -574.78M |
| December 31, 2024 | -463.66M |
| September 30, 2024 | -377.75M |
| June 30, 2024 | -374.93M |
| March 31, 2024 | -354.11M |
| December 31, 2023 | -328.07M |
| September 30, 2023 | -292.56M |
| Date | Value |
|---|---|
| June 30, 2023 | -259.99M |
| March 31, 2023 | -248.82M |
| December 31, 2022 | -239.48M |
| September 30, 2022 | -246.92M |
| June 30, 2022 | -233.90M |
| March 31, 2022 | -211.74M |
| December 31, 2021 | -186.48M |
| September 30, 2021 | -147.31M |
| June 30, 2021 | -123.76M |
| March 31, 2021 | -99.30M |
| December 31, 2020 | -87.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Absci Corp. | -121.08M |
| Twist Bioscience Corp. | -136.72M |
| Editas Medicine, Inc. | -73.95M |
| Amgen, Inc. | 8.743B |
| Halozyme Therapeutics, Inc. | 413.60M |